SomaLogic’s 7K SomaScan® Platform receives high marks in independent technical assessment by researchers at the National Institutes of Health
October 27, 2022 12:00 ET
|
SomaLogic Operating Company, Inc.
BOULDER, Colo., Oct. 27, 2022 (GLOBE NEWSWIRE) -- In a recent paper published earlier this month in Nature Scientific Reports, researchers at the National Institutes of Health conducted what may be...
SomaLogic to Announce Third Quarter 2022 Financial Results
October 24, 2022 16:30 ET
|
SomaLogic Operating Company, Inc.
BOULDER, Colo. and SAN DIEGO, Oct. 24, 2022 (GLOBE NEWSWIRE) -- SomaLogic (NASDAQ: SLGC), a leader in AI data-driven proteomics technology, today announced that it will report financial results for...
SomaLogic Announces the Appointment of Biotech Veteran Troy Cox as Executive Chairman of the Board of Directors
October 17, 2022 16:30 ET
|
SomaLogic Operating Company, Inc.
BOULDER, Colo. and SAN DIEGO, Oct. 17, 2022 (GLOBE NEWSWIRE) -- SomaLogic (NASDAQ: SLGC), a leader in AI data-driven proteomics technology, today announced the appointment of current board member...
SomaLogic's Chief Medical Officer Steve Williams honored with C-Suite Award by the Denver Business Journal
September 26, 2022 08:00 ET
|
SomaLogic, Inc.
BOULDER, Colo., Sept. 26, 2022 (GLOBE NEWSWIRE) -- SomaLogic (NASDAQ: SLGC), a leader in AI data-driven proteomics technology, today announced that Chief Medical Officer Steve Williams, M.D., Ph.D.,...
SomaLogic to Present at the Capital One Spatial Biology & Proteomics Summit
September 14, 2022 08:00 ET
|
SomaLogic, Inc.
BOULDER, Colo., Sept. 14, 2022 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in AI-data driven proteomics technology, today announced that management will be participating in the upcoming Capital...
SomaLogic to Present at Morgan Stanley 20th Annual Global Healthcare Conference
August 31, 2022 16:15 ET
|
SomaLogic, Inc.
BOULDER, Colo., Aug. 31, 2022 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in AI-data driven proteomics technology, today announced that the company will be participating in the upcoming Morgan...
SomaLogic Reports Second Quarter 2022 Financial Results
August 15, 2022 16:05 ET
|
SomaLogic, Inc.
Second quarter 2022 revenue of $14.1 million, bringing year to date revenue to $37.1 million.Reducing 2022 revenue guidance to $80-90 million to account for ongoing variability in core service...
SomaLogic acquires DNA nanotechnology leader Palamedrix to develop the next-generation SomaScan® Assay
July 26, 2022 08:00 ET
|
SomaLogic, Inc.
Brings differentiated miniaturization technology, scientific and engineering expertise, and enhanced ease-of-use capabilities to SomaLogic’s platform while expanding footprint to San Diego, CA ...
SomaLogic to Announce Second Quarter 2022 Financial Results
July 25, 2022 09:00 ET
|
SomaLogic, Inc.
BOULDER, Colo. , July 25, 2022 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in AI-data driven proteomics technology, today announced that it will report financial results for the second quarter...
SomaLogic Announces License Agreement with OncoHost for the Development of Precision Cancer Diagnostics
June 13, 2022 08:00 ET
|
SomaLogic, Inc.
BOULDER, Colo. and BINYAMINA, Israel, June 13, 2022 (GLOBE NEWSWIRE) -- SomaLogic (NASDAQ: SLGC), a leader in data-driven proteomics technology, today announced it has signed a licensing agreement...